Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results
Date:12/12/2011

used in operations was $56.5 million in fiscal 2011.
  • Net loss for fiscal 2011 was $60.6 million, or $0.51 per share, compared with a net loss of $26.7 million, or $0.30 per share for fiscal 2010.
  •  

    NUEDEXTA RevenueFor the quarter ended September 30, 2011, the company reported NUEDEXTA gross and net revenue of $4.3 million and $3.7 million respectively. Fourth quarter fiscal 2011 NUEDEXTA gross and net revenue increased 95% over the previous quarter. For Fiscal 2011, the company reported NUEDEXTA gross and net revenue of $7.0 million and $6.1 million respectively. NUEDEXTA revenue is recognized using a deferred revenue recognition model, meaning that NUEDEXTA capsule shipments to wholesalers are initially recorded as deferred revenue and later recognized as revenue when the product has left the distribution channel and is no longer subject to a right of return, effectively representing reported end-user prescriptions and non-retail shipments of NUEDEXTA capsules.

    Business HighlightsRecent highlights for the company include:

  • In October, the company announced that it had submitted an application to the European Medicines Agency (EMA) seeking marketing authorization for NUEDEXTA (dextromethorphan HBr and quinidine sulfate) for the treatment of pseudobulbar affect (PBA). Subsequently in November, the company announced that the EMA had accepted the filing of the Marketing Authorization Application (MAA) for NUEDEXTA for the treatment of PBA.
  • In November, the company announced that it had enrolled the first patient into the PRIME (Pain Research In Multiple sclErosis) study, an investigation of AVP-923 capsules for the treatment of central neuropathic pain in patients with multiple sclerosis.
  • Achieved record total NUEDEXTA prescriptions of 10,210 for the quarter ending September 30, 2011.
  •  

    Cash, Cash Equivalents & Marketable SecuritiesAs of September 30, 2011 Avanir h
    '/>"/>

    SOURCE Avanir Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
    2. Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference
    3. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
    4. Avanir Pharmaceuticals Submits European Marketing Authorization Application for NUEDEXTA
    5. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
    6. Avanir Pharmaceuticals to Participate in Two Investor Conferences
    7. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
    8. Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
    9. Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
    10. Avanir Pharmaceuticals Announces Appointment of Dr. Joao Siffert as Senior Vice President Research and Development
    11. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/11/2014)... July 11, 2014 Patient engagement has ... consequently, organizations are turning to an assortment of ... As part of this evolving approach to patient ... communicate and engage patients throughout their experiences with ... empowerment. By mapping the patient journey and employing ...
    (Date:7/11/2014)... July 11, 2014 According ... by Composition of Material, Application (Healthcare, Homeland security, ... Product (Personal Instrument, Hand-Held Instruments, Fixed, and Installed ... to 2013 - 2020", published by MarketsandMarkets, the Scintillator Market ... 5.62% from 2014 to 2020, and reach $479.16 ...
    (Date:7/11/2014)... -- On Thursday, July 10, 2014, ... Jones Industrial Average finished the day 0.42% lower at 16,915.07, ... losses were broad based as eight out of ten sectors ... Sector Index ended the day at 711.88, down 0.02%, while ... Investor-Edge has initiated coverage on the following equities: Covidien PLC ...
    Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4
    ... Inc. today announced that data from a Phase 1/2 study, ... Proceedings of the National Academy of Sciences, demonstrate the ... action human growth hormone, compared to therapy with native hormone. ... treated with ARX201, which was generated with Ambrx,s ReCODE™ technology. ...
    ... Korea, May 25, 2011 New findings presented from ... program showed that the safety profile of STELARA and ... time in adults with moderate to severe plaque psoriasis ... reported findings from an analysis of four placebo-controlled Phase ...
    Cached Medicine Technology:Proceedings of the National Academy of Sciences Report Superiority of Human Growth Hormone Generated with Ambrx Technology 2New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 2New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 3New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 4New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 5New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 6New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 7New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 8New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 9New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 10New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 11
    (Date:7/12/2014)... July 12, 2014 Sean Francis, owner of the ... special challenges to his clients. He’s also known for his support ... found a way to combine the two and is excited to ... for the Boys and Girls Club. , The funds are the ... on June 23rd. Francis sent out emails and asked his clients ...
    (Date:7/12/2014)... 12, 2014 Using and carrying around ... two inventors from Ashland, Va., decided that there needed ... inspired us to conceive of our design," he said. ... KIDNEY KOVER, which provides an inconspicuous way to use ... as well as promotes comfort and peace of mind. ...
    (Date:7/12/2014)... With prom shopping reaching its final days, VogueQueen.com, a ... showcase its new and trendy apparels. Recently, the company ... its online shop. Additionally, it is now providing huge ... According to the company’s sales manager, the promotion will ... , He says, “Now, worldwide clients can order cheap ...
    (Date:7/12/2014)... Wright & Schulte LLC has filed a ... subsidiary of Johnson & Johnson, on behalf of an Ohio ... a metal-on-metal DePuy Pinnacle hip replacement and had to undergo ... implant. The DePuy hip lawsuit was filed July 7, 2014, ... No. 3:14-cv-2427) where DePuy Pinnacle Hip lawsuit litigation is ...
    (Date:7/12/2014)... 12, 2014 Doylestown Hospital recently conducted ... of men’s health questions. Paddock tackles topics including ... why women live longer than men, and testosterone replacement ... Made Simple featured on Doylestown Hospital’s website, Dr. ... at any age. If you notice pain, bulging, or ...
    Breaking Medicine News(10 mins):Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 2Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 3Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2
    ... of scientists, led by H. Lundbeck A/S and King,s ... research academic-industry collaboration projects to find new methods for ... Novel Methods leading to New Medications in Depression ... top scientists from academic institutions with a wide range ...
    ... onPoint ... to announce that Joe Baffone, an 18-year oncology executive with Sanofi-Aventis has joined onPoint ... ... full service healthcare data solutions and reimbursement analytics firm, is proud to announce that ...
    ... , ... TBT Payment Acceptance Solutions offers merchant services across the southeast such as credit ... and loyalty cards. ,Whether you are a merchant in need of a payment ... with an established and trusted company, www.tbtpas.com allows for convenient access ...
    ... ... company CTW, Inc. of Mississippi and Massachusetts-based medical device manufacturer Tegra Medical to join ... ... private equity firm based in Boston, MA, is pleased to announce its majority investment ...
    ... , INDIANAPOLIS , Jan. ... solutions, has announced the completion of its $8 million ... Menlo Park, California .  The funding will allow Orbis ... and, in turn, help alleviate the nation,s wide-spread nursing shortages. ...
    ... , PORT-AU-PRINCE, Haiti , Jan. 19 , ... death toll likely well over 100,000 3 million people displaced or ... quake: 4 to 4.5 million) , Conditions in ... the quake are now scattered across 243 different locations in Port-au-Prince ...
    Cached Medicine News:Health News:Largest academic-industry collaboration for drug discovery in depression and schizophrenia launched 2Health News:Largest academic-industry collaboration for drug discovery in depression and schizophrenia launched 3Health News:Oncology Industry Veteran, Joe Baffone, Joins onPoint Oncology, LLC. 2Health News:TBT Payment Acceptance Solutions Announces Launch of Redesigned “User-Friendly” Website, www.tbtpas.com 2Health News:Riverside Partners Announces Acquisition of CTW, Inc. and Partnership with Tegra Medical 2Health News:Riverside Partners Announces Acquisition of CTW, Inc. and Partnership with Tegra Medical 3Health News:Riverside Partners Announces Acquisition of CTW, Inc. and Partnership with Tegra Medical 4Health News:Orbis Education Secures $8.0 Million in Funding for Expanding Online Nursing Education Platform 2Health News:Orbis Education Secures $8.0 Million in Funding for Expanding Online Nursing Education Platform 3Health News:Orbis Education Secures $8.0 Million in Funding for Expanding Online Nursing Education Platform 4Health News:World Vision Situation Update: More Aid Reaching Many Survivors, but Conditions Remain Dire 2Health News:World Vision Situation Update: More Aid Reaching Many Survivors, but Conditions Remain Dire 3
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: